Año
Autores / Publicación
Juárez Camacho, P., & Guise, T. (2010). TGF-Beta pathway as a therapeutic target in bone metastases. Current Pharmaceutical Design, 16(11), 1301-1312. doi: 10.2174/138161210791034049. (ID: 18220) (E)
Ponce Coria, J., San Cristobal, P., Kahle, K. T., Vazquez, N., Pacheco Alvarez, D., De Los Heros, P., Juárez Camacho, P., Muñoz, E., Michel, G., Bobadilla, N. A., Gimenez, I., Lifton, R. P., Hebert, S. C., & Gamba, G. (2008). Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proceedings of the National Academy of Sciences of the United States of America, 105(24), 8458-8463. doi: 10.1073/pnas.0802966105. (ID: 18221) (E)
Lopez Casillas, F., Vilchis Landeros, M., Esparza Lopez, J., Ponce Castañeda, M. V., Velasco Loyden, N. G., Juárez Camacho, P., Montiel, J. L., & Mendoza, V. (2008). Regulation of the Transforming Growth Factor-ß Superfamily by Betaglycan. In Sonia B. Jacowiew (Eds.), Transforming Growth Factor-ß in Cancer Therapy, Volumen I (1 ed., pp. 451-462). Humana Press. (ID: 18217) (E)
Hernandez, M., Cabrera Ponce, J. L., Fragoso, G., Lopez Casillas, F., Guevara Garcia, A., Rosas, G., Leon Ramirez, C., Juárez Camacho, P., Sanchez Garcia, G., Cervantes, J., Acero, G., Toledo, A., Cruz, C., Bojalil, R., Herrera Estrella, L., & Sciutto, E. (2007). A new highly effective anticysticercosis vaccine expressed in transgenic papaya. Vaccine, 25(21), 4252-4260. doi: 10.1016/j.vaccine.2007.02.080. (ID: 18222) (E)
Juárez Camacho, P., Vilchis Landeros, M., Ponce Coria, J., Mendoza, V., Bobadilla, N. A., Hernandez Pando, R., & Lopez Casillas, F. (2007). Soluble betaglycan reduces renal damage progression in db/db mice. American Journal of Physiology-Renal Physiology, 292(1), F321-F329. doi: 10.1152/ajprenal.00264.2006. (ID: 18223) (E)
Vilchis Landeros, M. M., Juárez Camacho, P., & Lopez Casillas, F. (2003). El papel fisiopatológico del TGF-beta en las nefropatías de diversas etiologías: los inhibidores del TGF-beta como inhibidores terapéuticos potenciales. Gaceta Médica de México, 139(2), 126-134. (ID: 18225) (E)
Feria, I., Pichardo, I., Juárez Camacho, P., Ramirez, V., Gonzalez, M. A., Uribe, N., Garcia Torres, R., Lopez Casillas, F., Gamba, G., & Bobadilla, N. A. (2002). Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney International, 63, 43-52. doi: 10.1046/j.1523-1755.2003.00707.x. (ID: 18623) (E)
Juárez Camacho, P., Sanchez López, R., Stock, R. P., Olvera, A., Ramos, M. A., & Alagon, A. (2001). Characterization of the Ehrab8 gene, a marker of the late stages of the secretory pathway of Entamoeba histolytica. Molecular and Biochemical Parasitology, 116(2), 223-228. doi: 10.1016/S0166-6851(01)00311-5. (ID: 18622) (E)
Juárez Camacho, P., Sanchez López, R., Ramos, M. A., Stock, R. P., & Alagon, A. (2000). Rab8 as a Molecular Model of Vesicular Trafficking to Investigate the Latter Steps of the Secretory Pathway in Entamoeba histolytica. Archives of Medical Research, 31(4), S157-S159. doi: 10.1016/S0188-4409(00)00111-9. (ID: 18620) (E)
Sanchez López, R., Gutiérrez, A., Juárez Camacho, P., Olvera, A., Olvera, F., Ramos, M. A., Sanchez, R., Saralegui, A., Stock, R. P., & Alagon, A. (2000). Molecular Genetics of the Secretory Pathway in Entamoeba histolytica: An Overview. Archives of Medical Research, 31(4), S151-S152. doi: 10.1016/S0188-4409(00)00108-9. (ID: 18621) (E)